Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1508 ARTÍCULOS , VIENDO DEL 1411 AL 1425

Comparing Alzheimer's and Parkinson's diseases networks using graph communities structure

Calderone A, Formenti M, Aprea F, Papa M, Alberghina L, Colangelo AM, Bertolazzi P.

BMC Syst Biol. 2016 Mar 2;10:25. doi: 10.1186/s12918-016-0270-7.

Retromer in Polarized Protein Transport

Vergés M.

Int Rev Cell Mol Biol. 2016;323:129-79. doi: 10.1016/bs.ircmb.2015.12.005. Epub 2016 Feb 3.

Influenza Vaccination Reduces Dementia Risk in Chronic Kidney Disease Patients: A Population-Based Cohort Study

Liu JC, Hsu YP, Kao PF, Hao WR, Liu SH, Lin CF, Sung LC, Wu SY.

Medicine (Baltimore). 2016 Mar;95(9):e2868. doi: 10.1097/MD.0000000000002868.

Glycation in Parkinson's disease and Alzheimer's disease

Vicente Miranda H, El-Agnaf OM, Outeiro TF.

Mov Disord. 2016 Jun;31(6):782-90. doi: 10.1002/mds.26566. Epub 2016 Mar 4.

Clinical drug research in chronic central neurodegenerative disorders

Müller T, Foley P.

Expert Rev Neurother. 2016 May;16(5):497-504. doi: 10.1586/14737175.2016.1163220. Epub 2016 Mar 21.

A Systematic Review of the Prevalence of Oropharyngeal Dysphagia in Stroke, Parkinson's Disease, Alzheimer's Disease, Head Injury, and Pneumonia

Takizawa C, Gemmell E, Kenworthy J, Speyer R.

Dysphagia. 2016 Jun;31(3):434-41. doi: 10.1007/s00455-016-9695-9. Epub 2016 Mar 12.

Structure of amyloid oligomers and their mechanisms of toxicities: Targeting amyloid oligomers using novel therapeutic approaches

Salahuddin P, Fatima MT, Abdelhameed AS, Nusrat S, Khan RH.

Eur J Med Chem. 2016 May 23;114:41-58. doi: 10.1016/j.ejmech.2016.02.065. Epub 2016 Mar 2.

Neuropathological basis of nonmotor manifestations of Parkinson's disease

Adler CH, Beach TG.

Mov Disord. 2016 Aug;31(8):1114-9. doi: 10.1002/mds.26605. Epub 2016 Mar 31.

Chronic Stress and Glucocorticoids: From Neuronal Plasticity to Neurodegeneration

Vyas S, Rodrigues AJ, Silva JM, Tronche F, Almeida OF, Sousa N, Sotiropoulos I.

Neural Plast. 2016;2016:6391686. doi: 10.1155/2016/6391686. Epub 2016 Mar 10.

Mechanisms of protein homeostasis in health, aging and disease

Goloubinoff P.

Swiss Med Wkly. 2016 Apr 5;146:w14306. doi: 10.4414/smw.2016.14306. eCollection 2016.

Omega-3 fatty acids for the treatment of dementia

Burckhardt M, Herke M, Wustmann T, Watzke S, Langer G, Fink A.

Cochrane Database Syst Rev. 2016 Apr 11;4(4):CD009002. doi: 10.1002/14651858.CD009002.pub3.

Advances in nanomedicine for the treatment of Alzheimer's and Parkinson's diseases

Hernando S, Gartziandia O, Herran E, Pedraz JL, Igartua M, Hernandez RM.

Nanomedicine (Lond). 2016 May;11(10):1267-85. doi: 10.2217/nnm-2016-0019. Epub 2016 Apr 14.

Mild cognitive impairment in Parkinson's disease versus Alzheimer's disease

Besser LM, Litvan I, Monsell SE, Mock C, Weintraub S, Zhou XH, Kukull W.

Parkinsonism Relat Disord. 2016 Jun;27:54-60. doi: 10.1016/j.parkreldis.2016.04.007. Epub 2016 Apr 9.

α-synuclein genetic variability: A biomarker for dementia in Parkinson disease

Guella I, Evans DM, Szu-Tu C, Nosova E, Bortnick SF; SNCA Cognition Study Group; Goldman JG, Dalrymple-Alford JC, Geurtsen GJ, Litvan I, Ross OA, Middleton LT, Parkkinen L, Farrer MJ.

Ann Neurol. 2016 Jun;79(6):991-9. doi: 10.1002/ana.24664. Epub 2016 May 5.

The crucial impact of lysosomes in aging and longevity

Carmona-Gutierrez D, Hughes AL, Madeo F, Ruckenstuhl C.

Ageing Res Rev. 2016 Dec;32:2-12. doi: 10.1016/j.arr.2016.04.009. Epub 2016 Apr 26.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias